Abstract
The goal of this research was to determine the relationship between the stage of chronic periodontitis and the presence of six bacterial pathogens (Aggregatibacter actinomycetemcomitans: AA, Fusobacterium nucleatum: FN, Porphyromonas gingivalis: PG, Prevotella intermedia: PI, Enterococcus faecalis: EF, and Parvimonas micra: PM). Forty-six chronic periodontitis patients visiting a dental hospital were included in this investigation. They were classified into four chronic periodontitis stages based on the sulcus bleeding index value and the probing depth. The tissue samples from the periodontal surgery were used for a direct PCR detection assay. A total of 49 samples from 46 patients were collected and classified into four chronic periodontitis groups (N: 6, P1: 13, P2: 18, P3: 12). The PCR assay showed that FN, PI, and PM were involved from the beginning of chronic periodontitis (P1), while AA and PG existed regardless of the disease stages. EF was strongly linked to the P3 stage of the disease. In order to assess the effect of dental treatments on patients with chronic periodontitis, EF should be a critical marker for P3 patients, while FN, PI, and PM would be good indicators for chronic periodontitis.
REFERENCES
2). Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol. 2000; 1997(14):216–48.
3). Socransky SS, Haffajee AD. The Bacterial Etiology of Destructive Periodontal Disease: Current Concepts. J Periodontol. 1992; 63:322–31.
4). Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol. 1984; 11:21–32.
5). Holt SC, Bramanti TE. Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med. 1991; 2:177–281.
6). Kinane DF, Demuth DR, Gorr SU, Hajishengallis GN, Martin MH. Human variability in innate immunity. Periodontol. 2000; 2007(45):14–34.
8). Liljemark WF, Bloomquist C. Human oral microbial ecology and dental caries and periodontal diseases. Crit Rev Oral Biol Med. 1996; 7:180–98.
9). Kayaoglu G, Ørstavik D. Virulence factors of Enterococcus faecalis: relationship to endodontic disease. Crit Rev Oral Biol Med. 2004; 15:308–20.
10). Stuart CH, Schwartz SA, Beeson TJ, Owatz CB. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endod. 2006; 32:93–8.
12). Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, et al. The human oral microbiome. J Bacteriol. 2010; 192:5002–17.
13). Buser D, Weber H, Lang NP. Tissue integration of non-submerged implants. l-year results of a prospective study with 100 ITI hollow-cylinder and hollow-screw implants. Clin Oral Implants Res. 1990; 1:33–40.
14). Mühlemann HR, Son S. Gingival sulcus bleeding–a leading symptom in initial gingivitis. Helv Odontol Acta. 1971; 15:107–13.
15). Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999; 4:1–6.
16). Miyagawa J, Maeda H, Murauchi T, Kokeguchi S, Yamabe K, Tanimoto I, et al. Rapid and simple detection of eight major periodontal pathogens by the loop-mediated isothermal amplification method. FEMS Immunol Med Microbiol. 2008; 53:314–21.
17). Williams JM, Trope M, Caplan DJ, Shugars DC. Detection and quantitation of E. faecalis by real-time PCR (qPCR), reverse transcription-PCR (RT-PCR), and cultivation during endodontic treatment. J Endod. 2006; 32:715–21.
18). Bizhang M, Ellerbrock B, Preza D, Raab W, Singh P, Beikler T, et al. Detection of nine microorganisms from the initial carious root lesions using a TaqMan-based real-time PCR. Oral Dis. 2011; 17:642–52.
19). Fine DH, Markowitz K, Furgang D, Velliyagounder K. Aggregatibacter actinomycetemcomitans as an early colonizer of oral tissues: epithelium as a reservoir? J Clin Microbiol. 2010; 48:4464–73.
20). Fine DH, Markowitz K, Fairlie K, Tischio-Bereski D, Ferrendiz J, Furgang D, et al. A consortium of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis is present in sites prior to bone loss in a longitudinal study of localized aggressive periodontitis. J Clin Microbiol. 2013; 51:2850–61.
21). Saito A, Inagaki S, Kimizuka R, Okuda K, Hosaka Y, Nakagawa T, et al. Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 2008; 54:349–55.
22). Rajapakse PS, O'Brien-Simpson NM, Slakeski N, Hoffmann B, Reynolds EC. Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model. Infect Immun. 2002; 70:2480–6.
23). O'Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, et al. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J Immunol. 2005; 175:3980–9.
24). Love RM. Enterococcus faecalis-a mechanism for its role in endodontic failure. Int Endod J. 2001; 34:399–405.
25). Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007; 449:811–8.
26). Souto R, Colombo AP. Prevalence of Enterococcus faecalis in subgingival biofilm and saliva of subjects with chronic periodontal infection. Arch Oral Biol. 2008; 53:155–60.
27). Kayaoglu G, Ørstavik D. Virulence factors of Enterococcus faecalis: relationship to endodontic disease. Crit Rev Oral Biol Med. 2004; 15:308–20.
Table 1.
Primer name | Primer sequence | Target pathogen1 | Amplicon size (bp) |
---|---|---|---|
AA F3 | 5′-TGCGTAGAGATGTGGAGGAA-3′ | AA | 165 |
AA B3 | 5′-GGCGGTCGATTTATCACGT-3′ | AA | 165 |
FN F3 | 5′-AGGCGATGATGGGTAGCC-3′ | FN | 214 |
FN B3 | 5′-AGCCGTCACTTCTTCTGTTG-3′ | FN | 214 |
PG F3 | 5′-GGTAAGTCAGCGGTGAAACC-3′ | PG | 218 |
PG B3 | 5′-GCGTGGACTACCAGGGTAT-3′ | PG | 218 |
PI F3 | 5′-ACGGCCTAATACCCGATGTT-3′ | PI | 193 |
PI B3 | 5′-CTGCCTCCCGTAGGAGTT-3′ | ||
EF16s-F | 5′-CGCTTCTTTCCTCCCGAGT-3′ | EF | 142 |
EF16s-R | 5′-GCCATGCGGCATAAACTG-3′ | ||
PM16s-F | 5′-TCGAACGTGATTTTTGTGGAAA-3′ | PM | 85 |
PM16s-R | 5′-GGTAGGTTGCTCACGTGTTACTCA-3′ | PM | 85 |
Table 2.
Sample number | Sampling data (yyyy.mm.dd) | Sex1/Age | Chronic periodontitis2 | AA3 | FN | PG | PI | EF | PM |
---|---|---|---|---|---|---|---|---|---|
1 | 2014.05.30 | M/54 | P2 | +4 | + | + | + | - | + |
2 | 2014.04.02 | F/45 | P2 | + | + | + | + | - | + |
3 | 2014.03.18 | M/52 | P1 | + | + | + | + | - | + |
4 | 2014.04.21 | F/53 | N | + | - | + | - | - | - |
5 | 2014.03.25 | M/48 | P2 | + | + | + | + | - | + |
6 | 2014.04.09 | F/18 | N | + | + | + | - | - | - |
7 | 2014.06.13 | M/60 | P2 | + | + | + | - | - | + |
8 | 2014.06.13 | F/57 | P2 | + | + | + | + | - | + |
9 | 2014.05.16 | M/58 | P1 | + | + | + | + | - | - |
10 | 2014.01.28 | M/52 | P2 | + | + | + | + | - | + |
11 | 2014.06.27 | M/42 | P2 | + | + | + | - | - | - |
12 | 2014.04.09 | F/68 | N | + | + | + | - | - | + |
13 | 2014.04.03 | M/35 | P2 | + | + | + | - | - | + |
14 | 2014.04.25 | M/51 | P2 | + | + | + | + | + | + |
15 | 2014.04.02 | F/59 | P2 | + | + | + | + | - | + |
16 | 2014.03.07 | M/39 | N | + | + | + | + | - | + |
17 | 2014.06.16 | M/54 | P2 | + | + | + | + | - | + |
18 | 2014.02.24 | F/42 | P2 | + | + | + | + | - | + |
19 | 2014.04.16 | M/53 | N | - | - | - | - | - | - |
20 | 2014.05.09 | F/48 | N | + | + | + | - | - | - |
21 | 2014.02.07 | M/60 | P2 | + | - | + | - | - | - |
22 | 2014.04.11 | F/64 | P2 | + | + | + | + | - | + |
23 | 2014.04.07 | M/49 | P1 | + | + | + | - | - | - |
24 | 2014.03.19 | F/43 | P2 | + | - | - | - | - | - |
25 | 2014.03.28 | M/46 | P3 | + | + | + | + | + | + |
26 | 2014.06.16 | F/53 | P3 | + | + | + | + | - | + |
27 | 2014.04.11 | F/51 | P3 | + | + | + | + | - | + |
28 | 2014.04.11 | F/35 | P3 | + | + | + | - | - | + |
29 | 2014.06.17 | F/53 | P3 | + | + | + | + | + | + |
30 | 2014.04.07 | F/59 | P3 | - | - | - | - | + | + |
31 | 2014.04.08 | M/53 | P3 | + | + | + | + | + | + |
32 | 2014.06.20 | M/45 | P3 | + | + | + | + | + | + |
33 | 2014.03.14 | F/52 | P3 | + | + | + | + | + | + |
34 | 2014.04.07 | F/42 | P3 | + | + | + | + | + | + |
35 | 2014.04.02 | F/55 | P3 | + | + | + | + | + | + |
36 | 2014.04.21 | F/47 | P3 | + | + | + | + | + | + |
37 | 2014.05.09 | M/49 | P1 | + | + | + | + | - | + |
38 | 2014.03.28 | M/61 | P1 | + | + | + | + | - | + |
39 | 2014.04.03 | M/47 | P1 | + | + | + | + | - | + |
40 | 2014.06.10 | F/55 | P1 | + | + | + | - | - | + |
41 | 2014.04.30 | F/46 | P1 | - | + | + | + | - | + |
42 | 2014.04.11 | F/51 | P1 | + | + | + | + | - | + |
43 | 2014.02.28 | M/38 | P1 | + | + | + | + | - | + |
44 | 2014.03.26 | M/48 | P2 | + | + | + | - | - | + |
45 | 2014.06.09 | M/54 | P1 | + | + | + | + | - | + |
46 | 2014.04.28 | F/48 | P1 | + | + | + | + | - | + |
47 | 2014.04.02 | M/37 | P2 | + | + | + | + | - | + |
48 | 2014.04.08 | M/48 | P2 | - | + | + | + | - | + |
49 | 2014.04.11 | M/52 | P1 | + | + | + | + | - | + |
Table 3.
Bacteria1 | No. of PCR positive samples/No. of samples used for PCR (%) | |||
---|---|---|---|---|
Sample groups classified by clinical measurement | ||||
N, Normal gingiva | P1, Mild chronic periodontitis (PAL2 ≤ 2 mm) | P2, Moderate chronic periodontitis (PAL ≤ 4 mm) | P3, Severe chronic periodontitis (PAL > 4 mm) | |
AA | 5/6 (83.3) | 12/13 (92.3) | 17/18 (94.4) | 11/12 (91.6) |
FN | 4/6 (66.7) | 13/13 (100) | 15/18 (83.3) | 11/12 (91.6) |
PG | 5/6 (83.3) | 13/13 (100) | 16/18 (88.8) | 11/12 (91.6) |
PI | 1/6 (16.7) | 11/13 (84.6) | 12/18 (66.7) | 10/12 (83.3) |
EF | 0/6 (0) | 0/13 (0) | 1/18 (5.5) | 9/12 (75.0) |
PM | 2/6 (33.3) | 12/13 (92.3) | 15/18 (83.3) | 12/12 (100) |